Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Aptuit (Oxford) Ltd | Abingdon, United Kingdom | Makes the active ingredient and tests it | Problems found, fixed voluntarilyAug 22, 2025 · 4 inspections |
| Patheon Manufacturing Services LLC | Ridgefield, NJ, United States | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMar 18, 2024 · 8 inspections |
Recalls
- Sep 1, 2016 · Class III · Sanofi-Aventis U.S. LLC
Labeling: Incorrect or Missing Package Insert
Lots: Lot #: 5RZ001C, 5RZ001D; Exp. 04/18 - Aug 4, 2016 · Class III · Genzyme Corporation / Genzyme Biosurgery
Labeling: Incorrect or Missing Lot and/or Exp. Date
Lots: Lot # 5RZ002; Exp. 04/18
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Plerixafor: every company that makes it
- Form
- injection, solution, subcutaneous
- Strength
- 24 mg per 1.2 mL
- Approval
- NDA NDA022311
- On the market since
- Sep 1, 2013
- Package NDCs
0024-5862-01- Official label
- DailyMed (National Library of Medicine), updated Sep 22, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?